Inosine,
does it really help with Improved endurance and exercise performance?
research showsThree double-blind crossover trials in trained runners and cyclists found no improvement in three-mile time, VO2peak, 20-30-minute cycling, Wingate, or sprint performance. One trial found a shorter high-intensity time to exhaustion than placebo, while serum urate repeatedly increased, resulting in F with 8 points.
ads claimMarketing states that inosine, as an ATP precursor or enhancer of red-cell 2,3-DPG, improves oxygen delivery and endurance. Human trials did not show higher 2,3-DPG or better performance, while urate increased.
Useful facts when choosing a product
- Exercise-trial doses were 5-10 g/day for two to ten days.
- Participants were trained male runners or cyclists.
- Running, steady cycling, Wingate, and repeated-sprint outcomes showed no benefit.
- Serum urate repeatedly increased after supplementation.
What the research actually shows
The Williams 1990 crossover trial gave 6 g/day for two days to nine trained runners and found no improvement in three-mile time, VO2peak, or time to exhaustion. The Starling 1996 crossover trial gave 5 g/day for five days to ten competitive cyclists and found no benefit in a 30-minute bout or Wingate test, while supramaximal time to exhaustion was about ten seconds shorter than with placebo. The McNaughton 1999 trial gave 10 g/day for five and ten days to seven trained men and found no benefit in a 20-minute time trial or sprint tests. All three studies observed higher urate.
Why this is classified as F (8)
Three independent double-blind crossover trials repeatedly found no performance benefit across different exercises and doses, while urate increased. One condition also showed worse performance, supporting F with 8 points.
Counterpoint. No large modern trial exists, but the direction of existing human trials is consistently null.
Rejudgment record. New verdict — Three independent double-blind crossover trials in trained runners and cyclists repeatedly found no aerobic or anaerobic performance benefit, with higher urate and some performance worsening
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Endurance and aerobic performance | F | Repeatedly null for three-mile running and 20-30-minute cycling performance |
| Anaerobic power and sprint performance | F | Wingate and repeated-sprint outcomes were null, and one supramaximal condition had a shorter time to exhaustion than placebo |
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Williams MH et al. 1990 | Double-blind placebo crossover trial | 9 | Unknown | Three-mile time, VO2peak, maximal time to exhaustion, 2,3-DPG, and urate | No running or VO2peak benefit after 6 g/day for two days; urate increased. | Key |
| Starling RD et al. 1996 | Placebo-controlled crossover exercise trial | 10 | Unknown | Wingate, 30-minute performance, supramaximal time to exhaustion, 2,3-DPG, and urate | No aerobic or power benefit; supramaximal time to exhaustion was shorter with inosine and urate increased. | Key |
| McNaughton L et al. 1999 | Randomized double-blind placebo-controlled trial | 7 | Unknown | Repeated sprints, 30-second sprint, 20-minute time trial, 2,3-DPG, and urate | Neither five nor ten days at 10 g/day improved performance or 2,3-DPG; urate increased. | Key |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-07-11).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-11 · Corrections: none
Cite this verdict
[Chamgap] Inosine x Improved endurance and exercise performance — Evidence Grade F·8. 3 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/sports/inosine-endurance-performance/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.